Search results
Results from the Tech24 Deals Content Network
[15] [16] In September 2021, another anti-vaccine conservative radio host, 62-year-old Bob Enyart, who "vocally refused to get vaccinated and actively spread false claims about the COVID-19 virus", died of COVID-19, prompting a new round of reports discussing the phenomenon within that demographic.
The treatment and management of COVID-19 combines both supportive care, which includes treatment to relieve symptoms, fluid therapy, oxygen support as needed, [1] [2] [3] and a growing list of approved medications. Highly effective vaccines have reduced mortality related to SARS-CoV-2; however, for those awaiting vaccination, as well as for the ...
CHICAGO -- Packaged foods giant Kraft Heinz said Carlos Abrams-Rivera, the company’s executive vice president and president of its North American business, will take over as chief executive Jan. 1.
Kraft Heinz CEO Carlos Abrams-Rivera eats just two meals a day, between 11 a.m. and 7 p.m., as part of his intermittent-fasting routine.
July 9, 2024 at 9:17 AM. (Reuters) -Pfizer said on Tuesday Chief Scientific Officer Mikael Dolsten, a key figure behind the development of its COVID-19 vaccine, would step down after a more than ...
v. t. e. ZF2001, trade-named Zifivax or ZF-UZ-VAC-2001, is an adjuvanted protein subunit COVID-19 vaccine developed by Anhui Zhifei Longcom in collaboration with the Institute of Microbiology at the Chinese Academy of Sciences. [1] [2] The vaccine candidate is in Phase III trials with 29,000 participants in China, Ecuador, Malaysia, Pakistan ...
Moderna, Inc. Moderna, Inc. ( / məˈdɜːrnə / mə-DUR-nə) [4] is an American pharmaceutical and biotechnology company based in Cambridge, Massachusetts, that focuses on RNA therapeutics, primarily mRNA vaccines. These vaccines use a copy of a molecule called messenger RNA (mRNA) to carry instructions for proteins to produce an immune response.
CoronaVac, also known as the Sinovac COVID-19 vaccine, [3] was a whole inactivated virus COVID-19 vaccine developed by the Chinese company Sinovac Biotech. [4] [5] It was phase III clinically trialled in Brazil, [6] Chile, [7] Indonesia, [8] the Philippines, [9] and Turkey [10] and relies on traditional technology similar to other inactivated ...